These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8388582)

  • 1. Postoperative deep venous thrombosis (DVT) and low-molecular weight heparin (LMWH) type and dosage.
    Wicky J; Couson F; Ambrosetti P; Didier D; Rohner A; Bounameaux H
    Thromb Haemost; 1993 Apr; 69(4):402-3. PubMed ID: 8388582
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of low molecular weight heparin in the prevention of postoperative deep venous thrombosis. Our experience in 88 cases].
    Verardi S; Cortese F; Baroni B; Boffo V; Casciani CU
    G Chir; 1989 Nov; 10(11):674-8. PubMed ID: 2562010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low molecular weight heparin: favorable effect profile for prevention and therapy of venous thrombosis].
    Marbet GA
    Ther Umsch; 1992 Dec; 49(12):843-9. PubMed ID: 1336627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery.
    Beghi C; Fragnito C; Antonelli A; Reverberi C; Ferrari P; Saccani S; Fesani F
    Int Angiol; 1993 Dec; 12(4):383-6. PubMed ID: 8207317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty. A meta-analysis of randomized trials.
    Howard AW; Aaron SD
    Thromb Haemost; 1998 May; 79(5):902-6. PubMed ID: 9609217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
    Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-benefit analysis of prophylaxis against deep vein thrombosis in surgery.
    Hauch O; Khattar SC; Jørgensen LN
    Semin Thromb Hemost; 1991; 17 Suppl 3():280-3. PubMed ID: 1661436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of granulocytes in the development of venous thrombosis in patients with hip fractures.
    Monreal M; Lafoz E; Arias A; Casals A
    Haemostasis; 1991; 21(1):45-50. PubMed ID: 1650746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
    Bergqvist D
    Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of low molecular weight heparin for prevention of deep vein thrombosis after total hip arthroplasty].
    Yang Z; Liu X; Dai S; Liu K; Zhang Y; Sun J; Yin X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Sep; 24(9):1058-61. PubMed ID: 20939473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.
    Pini M; Tagliaferri A; Manotti C; Lasagni F; Rinaldi E; Dettori AG
    Int Angiol; 1989; 8(3):134-9. PubMed ID: 2556484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of thrombosis in minimally invasive surgery].
    Harenberg J
    Zentralbl Chir; 1994; 119(6):447-8. PubMed ID: 8091883
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).
    Marassi A; Balzano G; Mari G; D'Angelo SV; Della Valle P; Di Carlo V; D'Angelo A
    Int Surg; 1993; 78(2):166-70. PubMed ID: 8394842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary prevention after deep venous thrombosis. Low molecular weight heparin versus coumarin].
    Hamann H
    Zentralbl Chir; 1999; 124(1):24-6. PubMed ID: 10091293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF; Hull RD
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin (fraxiparine) to prevent deep vein thrombosis in patients undergoing orthopedic surgery: a clinical report of two regimens.
    Drouet JC; Bernard JM; Bourreli B; Gunst JP
    Haemostasis; 1988; 18(2):135-6. PubMed ID: 2842239
    [No Abstract]   [Full Text] [Related]  

  • 17. Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
    Turpie AG
    Acta Chir Scand Suppl; 1988; 543():85-6. PubMed ID: 2847462
    [No Abstract]   [Full Text] [Related]  

  • 18. [What is assured in drug prevention of thrombosis with special reference to low molecular weight heparin?].
    Daiss W; Dölle W
    Internist (Berl); 1989 Dec; 30(12):784-9. PubMed ID: 2559898
    [No Abstract]   [Full Text] [Related]  

  • 19. Enoxaparin prophylaxis in elective hip surgery.
    Turpie AG
    Acta Chir Scand Suppl; 1990; 556():103-7. PubMed ID: 1963014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of standard unfractionated and low-molecular-weight heparins on platelets of patients undergoing total hip replacement surgery.
    Aulmann M; Kwasniki S; Böttiger BW; Meeder PJ
    Beitr Infusionsther Transfusionsmed; 1997; 34():242-7. PubMed ID: 9356680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.